Eli Lilly’s revenue has soared in recent years thanks to its leadership in the weight loss drug market. Eli Lilly (NYSE: LLY) ...

Abbott Laboratories earns the No. 2 rank among its peers in the Medical-Diversified industry group. Eli LillyLLY is the top-ranked stock within the group. This article was created ...

The Healthcare Select Sector SPDR Fund ETF is a sector ETF offering exposure to large-cap U.S. healthcare companies. Learn ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly (NYSE:LLY) announced a significant global licensing and research collaboration with Juvena Therapeutics to explore ...

Shares of Eli Lilly spiked 3.37% on June 10, hitting $800.04 before closing just under that at $799.78. This bump comes as ...

China-based biotech Innogen is making a strategic pivot toward international visibility following regulatory clearance of its ...

The market seems to share this optimistic view, since Eli Lilly and has a short interest of only 0.9% (this is the percentage ...

UBS is holding firm on its Buy rating and $1,050 price target for Eli Lilly, driven by faith in the upcoming SURPASS-CVOT ...

Aleniglipron’s tolerability could be a differentiator for Structure Therapeutics, but its efficacy lags competitors. Read why ...

United States Representative Gilbert Cisneros has executed a series of stock trades, with his picks in the defense sector ...

Economists around the world are expecting muted U.S. economic growth in the coming quarters, and some indicators suggest a mild recession is a possibility. It may become difficult for investors ...